Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1985 Sep;22(3):387–390. doi: 10.1128/jcm.22.3.387-390.1985

Evaluation of antibiotic susceptibility testing by agar dilution and the Micro Media system (Fox Panel).

W D Welch, M A Layman, L Chiles, R Ragsdale, E Kutscher, P M Southern Jr
PMCID: PMC268416  PMID: 3850093

Abstract

The susceptibilities of 350 gram-positive cocci and 638 gram-negative bacilli to various antimicrobial agents were compared by using the Micro-Media system (MMS) (Fox Panel) (Micro-Media Systems, Inc., Potomac, Md.) and a standard agar dilution procedure. Major discrepancies occurred with enterococci, among which 48 of 53 isolates (91%) were found to be resistant to penicillin G by agar dilution and reported as susceptible by the MMS. Other large discrepancies occurred with Staphylococcus aureus and Acinetobacter calcoaceticus subsp. anitratus, among which more than 40% of the isolates were judged to be resistant to ampicillin by agar dilution and susceptible by the MMS. In terms of overall agreement in interpretation of MICs by the two systems, an agreement of greater than 84% was seen for both gram-positive and gram-negative organisms when ampicillin and cephalothin (68 and 78% agreement for gram-positive cocci, respectively) were excluded. These disagreements in MIC interpretations may result in part from the small number of organisms tested per well (4,000 CFU) in the MMS, as compared with 10,000 CFU per test in the agar dilution method.

Full text

PDF
387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Jones R. N., Gavan T. L. Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: a collaborative study. Antimicrob Agents Chemother. 1978 Jan;13(1):61–69. doi: 10.1128/aac.13.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergan T., Lernestedt J. O. Antibiotic resistance in staphylococci from a hospital environment. Chemotherapy. 1983;29(1):28–36. doi: 10.1159/000238170. [DOI] [PubMed] [Google Scholar]
  3. Bushby S. R. Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy. Postgrad Med J. 1969 Nov;45(Suppl):10–18. [PubMed] [Google Scholar]
  4. Cherne J. E., Peterson L. R. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli with a cation-supplemented inoculum. Antimicrob Agents Chemother. 1980 Jul;18(1):210–211. doi: 10.1128/aac.18.1.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cullmann W., Opferkuch W., Stieglitz M., Dick W. Influence of spontaneous and inducible beta-lactamase production on the antimicrobial activity of recently developed beta-lactam compounds. Chemotherapy. 1984;30(3):175–181. doi: 10.1159/000238265. [DOI] [PubMed] [Google Scholar]
  6. Darrell J. H., Garrod L. P., Waterworth P. M. Trimethoprim: laboratory and clinical studies. J Clin Pathol. 1968 Mar;21(2):202–209. doi: 10.1136/jcp.21.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Edson R. S., Keys T. F. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin. Mayo Clin Proc. 1983 Feb;58(2):99–102. [PubMed] [Google Scholar]
  8. Mills J., Drew D. Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse. Ann Intern Med. 1976 Jan;84(1):29–35. doi: 10.7326/0003-4819-84-1-29. [DOI] [PubMed] [Google Scholar]
  9. Moellering R. C., Jr, Watson B. K., Kunz L. J. Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci. Am J Med. 1974 Aug;57(2):239–250. doi: 10.1016/0002-9343(74)90448-3. [DOI] [PubMed] [Google Scholar]
  10. Pedersen M. M., Marso E., Pickett M. J. Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility. Am J Clin Pathol. 1970 Aug;54(2):178–192. doi: 10.1093/ajcp/54.2.178. [DOI] [PubMed] [Google Scholar]
  11. Peterson L. R., Gerding D. N., Johnson M. M., Cherne J. E., Opfer B. J., Hall W. H. Evaluation of a commercial microdilution system for quantitative susceptibility testing of aminoglycosides against multidrug-resistant, gram-negative bacilli. Antimicrob Agents Chemother. 1980 Jan;17(1):20–23. doi: 10.1128/aac.17.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Toala P., McDonald A., Wilcox C., Finland M. Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences. Am J Med Sci. 1969 Dec;258(6):416–430. doi: 10.1097/00000441-196912000-00006. [DOI] [PubMed] [Google Scholar]
  13. Verbist L. In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob Agents Chemother. 1978 Mar;13(3):349–357. doi: 10.1128/aac.13.3.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Waitz J. A., Moss E. L., Jr, Drube C. G., Weinstein M. J. Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin. Antimicrob Agents Chemother. 1972 Dec;2(6):431–437. doi: 10.1128/aac.2.6.431. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES